Caris Life Sciences Adds Florida Cancer Center to its Oncology Alliance

Irving-based Caris Life Sciences will be adding a 26th cancer center to its Precision Oncology Alliance when the Sylvester Comprehensive Cancer Center at the Miami Miller School of Medicine joins the group. The alliance is a network of cancer centers that work together to develop standards of care and best practices to improve cancer treatment. Caris Life Sciences is a biotechnology company that addresses cancer and other diseases through several platforms that inform drug development and other treatment. The Precision Oncology Alliance helps lead the development of precision cancer care, and the Miami center will add to the alliance’s collection of… Full Story

Former UTSW Neuroscience Chair Wins Nobel Prize

Dr. Thomas C. Südhof, adjunct professor of neuroscience and former chairman of the department at UT Southwestern Medical Center, was named a 2013 Nobel Prize winner for medicine Monday, for his and others’ research into how cellular transport systems work. Südhof earned the prize alongside James Rothman and Randy Schekman. “I’m absolutely surprised,” said Südhof. “Every scientist dreams of this. I didn’t realize there was chance I would be awarded the prize. I am stunned and really happy to share the prize with James Rothman and Randy Schekman.” Südhof, now at Stanford University’s medical school, was recognized for work performed at UT Southwestern on… Full Story

Morning Rounds (04.29.13)

Acute- and long-term-care hospitals will see small increases in Medicare payments beginning in 2014, under a proposed payment schedule released Friday by the Centers for Medicare and Medicaid Services Services.

Dallas-based Tenet Healthcare was among the 25 hospitals featured in the Healthier Hospitals Initiative’s 2012 Milestone Report.

Researchers at UT Southwestern Medical Center have found that alternative splicing—a process that allows a single gene to code for multiple proteins—appears to be a new potential target for anti-telomerase cancer therapy. Full Story

UTSW Research Unveils Possible Cancer Therapy Target

Researchers at UT Southwestern Medical Center have found that alternative splicing—a process that allows a single gene to code for multiple proteins—appears to be a new potential target for anti-telomerase cancer therapy. The enzyme telomerase is overexpressed in almost all cancer cells, and previous research efforts have failed to identify good telomerase inhibitors. The study by Dr. Woodring Wright and UT Southwestern colleagues in the April 4 issue of Cell Reports identifies a new approach for inhibiting telomerase, which is an enzyme that drives uncontrolled division and replication of cancer cells.

Fitch: Slow Growth for Healthcare Sector in 2013

Fitch Ratings forecasts low single-digit growth for most companies in the U.S. healthcare sector in 2013, although the ratings agency’s overall outlook for the industry is stable. Its forecast covers pharmaceutical manufacturers, diagnostic and life science companies, healthcare providers, medical device makers, and healthcare services segments of the broader U.S. healthcare industry: Fitch says healthcare shows many positive growth trends—including the country’s aging population and higher rates of chronic disease, growing demand in emerging markets, and new product launches. But these are tempered by weak economic conditions and the looming fiscal cliff. Although Fitch views the Affordable Care Act as a… Full Story